Related Experiment Video
Updated: Feb 19, 2026

09:11
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
1.2K
90Y/177Lu-DOTATATE therapy: survival of the fittest?
Abstract
No abstract available in PubMed .

